Tumor Microenvironment-Responsive One-for-All Molecular-Engineered Nanoplatform Enables NIR-II Fluorescence Imaging-Guided Combinational Cancer Therapy
Analytical Chemistry · 2023
DOI: 10.1021/acs.analchem.3c03827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2023. Verfasst von Gui-Long Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hen…. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: University of South China Clinical Research 4310 Program, the Science and Technology Innovation Program of Hunan Province ?Huxiang Young Talents Plan?, the Key Research and Development Program of Hunan Province of China.
Abstract (Originalsprache)
The activable NIR-based phototheranostic nanoplatform (NP) is considered an efficient and reliable tumor treatment due to its strong targeting ability, flexible controllability, minimal side effects, and ideal therapeutic effect. This work describes the rational design of a second near-infrared (NIR-II) fluorescence imaging-guided organic phototheranostic NP (FTEP-TBFc NP). The molecular-engineered phototheranostic NP has a sensitive response to glutathione (GSH), generating hydrogen sulfide (H2S) gas, and delivering ferrocene molecules in the tumor microenvironment (TME). Under 808 nm irradiation, FTEP-TBFc could not only simultaneously generate fluorescence, heat, and singlet oxygen but also greatly enhance the generation of reactive oxygen species to improve chemodynamic therapy (CDT) and photodynamic therapy (PDT) at a biosafe laser power of 0.33 W/cm2. H2S inhibits the activity of catalase and cytochrome c oxidase (COX IV) to cause the enhancement of CDT and hypothermal photothermal therapy (HPTT). Moreover, the decreased intracellular GSH concentration further increases CDT's efficacy and downregulates glutathione peroxidase 4 (GPX4) for the accumulation of lipid hydroperoxides, thus causing the ferroptosis process. Collectively, FTEP-TBFc NPs show great potential as a versatile and efficient NP for specific tumor imaging-guided multimodal cancer therapy. This unique strategy provides new perspectives and methods for designing and applying activable biomedical phototheranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Huna…
- Department of Radiology, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China.
- MOE Key Lab of Rare Pediatric Diseases, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
- National Health Commission Key Laboratory of Birth Defect Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, Hunan, China.
ORCID-Profile: Qinglai Yang
Förderung
- University of South China Clinical Research 4310 Program
- the Science and Technology Innovation Program of Hunan Province ?Huxiang Young Talents Plan?
- the Key Research and Development Program of Hunan Province of China
- the Scientific research project of the Hunan Provincial Health Commission of China
- the Scientific Research Fund of Hunan Province Education Department
- Hunan Provincial Clinical Medical Technology Innovation Guide Project
- the Natural Science Foundation of Hunan Province of China
- the National Natural Science Foundation of China
Zitieren
APA
Wu, G. L., Liu, F., Li, N., Wang, F., Yang, S., Wu, F., Xiao, H., Wang, M., Deng, S., Kuang, X., Fu, Q., Wu, P., Kang, Q., Sun, L., Li, Z., Lin, N., Wu, Y., Tan, S., Chen, G., …, & Yang, Q. (2023). Tumor Microenvironment-Responsive One-for-All Molecular-Engineered Nanoplatform Enables NIR-II Fluorescence Imaging-Guided Combinational Cancer Therapy. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c03827
Vancouver
Wu GL, Liu F, Li N, Wang F, Yang S, Wu F, et al. Tumor Microenvironment-Responsive One-for-All Molecular-Engineered Nanoplatform Enables NIR-II Fluorescence Imaging-Guided Combinational Cancer Therapy. Analytical Chemistry. 2023. doi:10.1021/acs.analchem.3c03827
BibTeX
@article{Wu2023,
author = {Wu, Gui-Long and Liu, Fen and Li, Na and Wang, Feirong and Yang, Sha and Wu, Fan and Xiao, Hao and Wang, Minghui and Deng, Sanling and Kuang, Xin and Fu, Qian and Wu, Peixian and Kang, Qiang and Sun, Lijuan and Li, Zelong and Lin, Nanyun and Wu, Yinyin and Tan, Senyou and Chen, Guodong and Tan, Xiaofeng and Yang, Qinglai},
title = {Tumor Microenvironment-Responsive One-for-All Molecular-Engineered Nanoplatform Enables NIR-II Fluorescence Imaging-Guided Combinational Cancer Therapy},
journal = {Analytical Chemistry},
year = {2023},
doi = {10.1021/acs.analchem.3c03827}
}
EUVIMED